Adherence in patients in the first year after kidney transplantation and its impact on graft loss and mortality: A cross-sectional and prospective study

Journal of Advanced Nursing

Volumn 70, Issue 12, 2014, Pages 2871-2883

  Prihodova, Lucia ^a   Nagyova, Iveta ^a   Rosenberger, Jaroslav ^a,b,c   Majernikova, Maria ^a,b,c   Roland, Robert ^b,c   Groothoff, Johan W ^d   van Dijk, Jitse P ^a,d  

^a Med Faculty of Safarik University   (Slovakia)

^b Nephrology and Dialysis Center Fresenius   (Slovakia)

^c L PASTEUR UNIVERSITY HOSPITAL   (Slovakia)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Adherence; Graft loss; Kidney transplantation; Mortality; Nurses nursing; Side effects; Social support

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; AGED; CHILD; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DRUG EFFECTS; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; MORTALITY; PATIENT COMPLIANCE; PROSPECTIVE STUDY; REHABILITATION; SEX DIFFERENCE; SLOVAKIA; SOCIAL SUPPORT; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; SEX FACTORS; SLOVAKIA; SOCIAL SUPPORT; SOCIOECONOMIC FACTORS; SURVIVAL RATE; YOUNG ADULT;

EID: 84909957671     PISSN: 03092402     EISSN: 13652648     Source Type: Journal    
DOI: 10.1111/jan.12447     Document Type: Article

References (52)

1. Brickman A.L. & Yount S.E. (1996) Noncompliance in end-stage renal disease: a threat to quality of care and cost containment. Journal of Clinical Psychology in Medical Settings 3(4), 399-412.
2. Butler J.A., Roderick P., Mullee M., Mason J.C. & Peveler R.C. (2004) Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review. Transplantation 77(5), 769-776.
3. Chisholm-Burns M., Pinsky B., Parker G., Johnson P., Arcona S., Buzinec P., Chakravarti P., Good M. & Cooper M. (2012) Factors related to immunosuppressant medication adherence in renal transplant recipients. Clinical Transplantation 26(5), 706-713.
4. Cohen S.D., Patel S.S., Khetpal P., Peterson R.A. & Kimmel P.L. (2007) Pain, sleep disturbance and quality of life in patients with chronic kidney disease. Clinical Journal of the American Society of Nephrology 2(5), 919-925.
5. Couzi L., Moulin B., Morin M., Albano L., Godin M., Barrou B., Alamartine E., Morelon E., Girardot-Seguin S., Mendes L., Misdrahi D., Cassuto E. & Merville P. (2013) Factors predictive of medication nonadherence after renal transplantation: a French observational study. Transplantation 95(2), 326-332.
6. De Geest S., Borgermans L., Gemoets H., Abraham I., Vlaminck H., Evers G. & Vanrenterghem Y. (1995) Incidence, determinants and consequences of subclinical noncompliance with immunosuppressive therapy in renal-transplant recipients. Transplantation 59(3), 340-347.
7. De Geest S., Abraham I., Moons P., Vandeputte M., van Cleemput J., Evers G., Daenen W. & Vanhaecke J. (1998) Late acute rejection and subclinical noncompliance with cyclosporine therapy in heart transplant recipients. The Journal of Heart and Lung 17(9), 854-863.
8. Denhaerynck K., Dobbels F., Cleemput I., Desmyttere A., Schafer-Keller P., Schaub S. & De Geest S. (2005) Prevalence, consequences and determinants of nonadherence in adult renal transplant patients: a literature review. Transplant International 18(10), 1121-1133.
9. Denhaerynck K., Steiger J., Bock A., Schafer-Keller P., Kofer S., Thannberger N. & De Geest S. (2007) Prevalence and risk factors of non-adherence with immunosuppressive medication in kidney transplant patients. American Journal of Transplantation 7(1), 108-116.
10. Denhaerynck K., Burkhalter F., Schafer-Keller P., Steiger J., Bock A. & De Geest S. (2009) Clinical consequences of non adherence to immunosuppressive medication in kidney transplant patients. Transplant International 22(4), 441-446.
11. Dharancy S., Giral M., Tetaz R., Fatras M., Dubel L. & Pageaux G. (2012) Adherence with immunosuppressive treatment after transplantation: results from the French trial PREDICT. Clinical Transplantation 26(3), E293-E299.
12. Dickenmann M.J., Nickeleit V., Tsinalis D., Gurke L., Mihatsch M.J. & Thiel G. (2002) Why do kidney grafts fail? A long-term single-center experience. Transplant International 15(9-10), 508-514.
13. DiMatteo M.R. (2004) Social support and patient adherence to medical treatment: a meta-analysis. Health Psychology 23(2), 207-218.
14. Fine R.N., Becker Y., De Geest S., Eisen H., Ettenger R., Evans R., Rudow D.L., McKay D., Neu A., Nevins T., Reyes J., Wray J. & Dobbels F. (2009) Nonadherence consensus conference summary report. American Journal of Transplantation 9(1), 35-41.
15. Franke G.H., Reimer J., Kohnle M., Luetkes P., Maehner N. & Heemann U. (1999) Quality of life in end-stage renal disease patients after successful kidney transplantation: development of the ESRD symptom checklist - Transplantation module. Nephron 83(1), 31-39.
16. Franke G.H., Reimer J., Philipp T. & Heemann U. (2003) Aspects of quality of life through end-stage renal disease. Quality of Life Research 12(2), 103-115.
17. Franke G.H., Trampenau C., Reimer J. & Switch Tacrolimus Ciclosporin (2006) Switching from cyclosporine to tacrolimus leads to improved disease-specific quality of life in patients after kidney transplantation. Transplantation Proceedings 38(5), 1293-1294.
18. Greenstein S. & Siegal B. (1998) Compliance and noncompliance in patients with a functioning renal transplant: a multicenter study. Transplantation 66(12), 1718-1726.
19. Greenstein S. & Siegal B. (1999) Odds probabilities of compliance and noncompliance in patients with a functioning renal transplant: a multicenter study. Transplantation Proceedings 31(1-2), 280-281.
20. Griva K., Davenport A., Harrison M. & Newman S.P. (2012) Non-adherence to immunosuppressive medications in kidney transplantation: intent vs. forgetfulness and clinical markers of medication intake. Annals of Behavioral Medicine 44(1), 85-93.
21. Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group (2009) KDIGO clinical practice guideline for the care of kidney transplant recipients. American Journal of Transplantation 9(Suppl 3), S1-S155.
22. Kimmel P.L., Peterson R.A., Weihs K.L., Simmens S.J., Alleyne S., Cruz I. & Veis J.H. (1998) Psychosocial factors, behavioral compliance and survival in urban hemodialysis patients. Kidney International 54(1), 245-254.
23. Korb-Savoldelli V., Sabatier B., Gillaizeau F., Guillemain R., Prognon P., Begue D. & Durieux P. (2010) Non-adherence with drug treatment after heart or lung transplantation in adults: a systematic review. Patient Education and Counseling 81(2), 148-154.
24. Laederach-Hofmann K. & Bunzel B. (2000) Noncompliance in organ transplant recipients: a literature review. General Hospital Psychiatry 22(6), 412-424.
25. Laupacis A., Keown P., Pus N., Krueger H., Ferguson B., Wong C. & Muirhead N. (1996) A study of the quality of life and cost-utility of renal transplantation. Kidney International 50(1), 235-242.
26. Levey A.S. & Stevens L.A. (2010) Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates and better risk predictions. American Journal of Kidney Diseases 55(4), 622-627.
27. Levey A.S., Stevens L.A., Schmid C.H., Zhang Y., Castro A.F. III, Feldman H.I., Kusek J.W., Eggers P., Van Lente F., Greene T., Coresh J. & Chronic Kidney Dis Epidemiology Co (2009) A new equation to estimate glomerular filtration rate. Annals of Internal Medicine 150(9), 604-612.
28. Massey E.K., Tielen M., Laging M., Beck D.K., Khemai R., van Gelder T. & Weimar W. (2013) The role of goal cognitions, illness perceptions and treatment beliefs in self-reported adherence after kidney transplantation: a cohort study. Journal of Psychosomatic Research 75(3), 229-234.
29. Matas A.J., Halbert R.J., Barr M.L., Helderman J.H., Hricik D.E., Pirsch J.D., Schenkel F.A., Siegal B.R., Liu H. & Ferguson R.M. (2002) Life satisfaction and adverse effects in renal transplant recipients: a longitudinal analysis. Clinical Transplantation 16(2), 113-121.
30. Mitchell B., Armour C., Lee M., Song Y.J., Stewart K., Peterson G., Hughes J., Smith L. & Krass I. (2011) Diabetes Medication Assistance Service: the pharmacist's role in supporting patient self-management of type 2 diabetes (T2DM) in Australia. Patient Education and Counseling 83(3), 288-294.
31. Moons P., De Geest S., Abraham I., Van Cleemput J. & Vanhaecke J. (1998) Symptom experience associated with maintenance Immunosuppression after heart transplantation: patients' appraisal of side effects. Heart and Lung 27(5), 315-325.
32. Moons P., Vanrenterghem Y., Van Hooff J.P., Squifflet J.P., Margodt D., Mullens M., Thevissen I. & De Geest S. (2003) Health-related quality of life and symptom experience in tacrolimus-based regimens after renal transplantation: a multicentre study. Transplant International 16(9), 653-664.
33. Morrissey P.E., Flynn M.L. & Lin S. (2007) Medication noncompliance and its implications in transplant recipients. Drugs 67(10), 1463-1481.
34. Murray M.D., Morrow D.G., Weiner M., Clark D.O., Tu W., Deer M.M., Brater D.C. & Weinberger M. (2004) A conceptual framework to study medication adherence in older adults. The American Journal of Geriatric Pharmacotherapy 2(1), 36-43.
35. Nagyova I., Benka J., Chylova M., van Dijk J.P., Dubayova T., Havlikova E., Katreniakova Z., Prihodova L., Rosenberger J., Sudzinova A., Skodova Z. & Vargova H. (2009) Measuring Health and Quality of Life in the Chronically Ill. EQUILIBRIA Ltd, Kosice, Slovakia.
36. Nevins T.E. & Matas A.J. (2004) Medication noncompliance: another iceberg's tip. Transplantation 77(5), 776-778.
37. Nevins T.E. & Thomas W. (2009) Quantitative patterns of azathioprine adherence after renal transplantation. Transplantation 87(5), 711-718.
38. Penn C., Watermeyer J. & Evans M. (2011) Why don't patients take their drugs? The role of communication, context and culture in patient adherence and the work of the pharmacist in HIV/AIDS. Patient Education and Counseling 83(3), 310-318.
39. Raiz L.R., Kilty K.M., Henry M.L. & Ferguson R.M. (1999) Medication compliance following renal transplantation. Transplantation 68(1), 51-55.
40. Reimer J., Franke G.H., Philipp T. & Heemann U. (2002) Quality of life in kidney recipients: comparison of tacrolimus and cyclosporine-microemulsion. Clinical Transplantation 16(1), 48-54.
41. Rosenberger J., Geckova A.M., van Dijk J.P., Nagyova I., Roland R., van den Heuvel W.J. & Groothoff J.W. (2005) Prevalence and characteristics of noncompliant behaviour and its risk factors in kidney transplant recipients. Transplant International 18(9), 1072-1078.
42. Russell C.L., Cetingok M., Hamburger K.Q., Owens S., Thompson D., Hathaway D., Winsett R.P., Conn V.S., Madsen R., Sitler L. & Wakefield M.R. (2010) Medication adherence in older renal transplant recipients. Clinical Nursing Research 19(2), 95-112.
43. Russell C.L., Ashbaugh C., Peace L., Cetingok M., Hamburger K.Q., Owens S., Coffey D., Webb A.W., Hathaway D., Winsett R.P., Madsen R. & Wakefield M.R. (2013) Time-in-a-bottle (TIAB): a longitudinal, correlational study of patterns, potential predictors and outcomes of immunosuppressive medication adherence in adult kidney transplant recipients. Clinical Transplantation 27(5), E580-E590.
44. Schafer-Keller P., Steiger J., Bock A., Denhaerynck K. & De Geest S. (2008) Diagnostic accuracy of measurement methods to assess non-adherence to immunosuppressive drugs in kidney transplant recipients. American Journal of Transplantation 8(3), 616-626.
45. Schmid-Mohler G., Thut M.P., Wuthrich R.P., Denhaerynck K. & De Geest S. (2010) Non-adherence to immunosuppressive medication in renal transplant recipients within the scope of the integrative model of behavioral prediction: a cross-sectional study. Clinical Transplantation 24(2), 213-222.
46. Shidler N.R., Peterson R.A. & Kimmel P.L. (1998) Quality of life and psychosocial relationships in patients with chronic renal insufficiency. American Journal of Kidney Diseases 32(4), 557-566.
47. Siegal B.R. & Greenstein S.M. (1997) Postrenal transplant compliance from the perspective of African-Americans, Hispanic-Americans and Anglo-Americans. Advances in Renal Replacement Therapy 4(1), 46-54.
48. Takemoto S.K., Pinsky B.W., Schnitzler M.A., Lentine K.L., Willoughby L.M., Burroughs T.E. & Bunnapradist S. (2007) A retrospective analysis of immunosuppression compliance, dose reduction and discontinuation in kidney transplant recipients. American Journal of Transplantation 7(12), 2704-2711.
49. Vasquez E.M., Tanzi M., Benedetti E. & Pollak R. (2003) Medication noncompliance after kidney transplantation. American Journal of Health-System Pharmacy 60(3), 266-269.
50. Wolfe R.A., Ashby V.B., Milford E.L., Ojo A.O., Ettenger R.E., Agodoa L.Y.C., Held P.J. & Port F.K. (1999) Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation and recipients of a first cadaveric transplant. New England Journal of Medicine 341(23), 1725-1730.
51. World Health Organisation (2003) Adherence to Long Term Therapies. Evidence for Action. World Health Organisation, Switzerland.
52. Zimet G.D., Dahlem N.W., Zimet S.G. & Farley G.K. (1988) The multidimensional scale of perceived social support. Journal of Personality Assessment 52(1), 30-41.